The man who grew a finger

more here

Open biohacking kit project

contains information on important protocols in genetic engineering, stem cell research, microbiology and
other fields of related interest.
more here

Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery.

morehere

The prize of biofuel

part 1
part 2
part 3

Human Fertilisation and Embryology Bill

aa view from the British Deaf Association

The BDA has acted as a respondent agent on behalf of the Deaf community, and a draft letter [PDF] has gone to Professor Marcus Pembrey (Professor of Paediatric Genetics), who is acting as an advisor to the House of Lords on amendments to the Human Fertilisation and Embryology Bill.

See also:
HFEB: Explanatory clause on deaf selection
Parliament: Deaf Embryo selection to be made illegal

Stem Cells without the Embryos

An easy method for reprogramming adult cells may resolve ethical objections. more here

Cloning

A technical breakthrough has enabled scientists to create for the first
time dozens of cloned embryos from adult monkeys, raising the prospect
of the same procedure being used to make cloned human embryos.
morehere

MIT develops ‘tractor beam’ for cells

morehere

Good, Better, Best: The Human Quest for Enhancement

report of this now online
Summary Report of an Invitational Workshop
Convened by the Scientific Freedom, Responsibility and Law Program
American Association for the Advancement of Science
June 1-2, 2006
more here

BT Eyes Technology Revolution for the Pharma Industry

In a white paper, ‘Pharma Futurology: Joined Up Healthcare, 2016 and beyond’, BT’s pharmaceutical division brings its expertise in connecting people and businesses to create a big-picture outlook for the industry. The research reveals expected technology inspired changes that threaten pharmaceutical companies with isolation from an increasingly patient-centric healthcare community.
morehere

new column of mine is out Bionics

seehere

The Nanoparticle Drug Delivery Market Report

here
and excerpts here

“DNA shadow nanolithography”

more here

Nanotechnologies Set to Shake Up and Shake Out Drug Delivery Market

LONDON–(BUSINESS WIRE)–Aug 21, 2007 - A new report from Cientifica Ltd., “The Nanoparticle Drug Delivery Market”, identifies who is positioned to be the “winners” and “losers” in the drug delivery market as new nanoparticles and nanostructured delivery techniques begin replacing existing polymer therapeutics that currently dominate the market.

The report, available at www.cientifica.com, projects that the total market for nanotechnology-enabled drug delivery will rise to $26 billion by 2012 from its current size of $3.39 billion, representing a compound annual growth rate of 37%.

But this is just the beginning; the market could steeply rise after 2012, reaching potentially $220 billion by 2015 for these nano-enabled compounds.
see more here

NBICS and Climate Change

my new column out

Microbial Fuel Cells

more here

Making Deaf Ears Hear with Light

more here

Newest column of mine NBICS, Cultural Identity and Diversity, and the CBD

NBICS, Cultural Identity and Diversity, and the CBD
this is the second part on the convention on biological diversity CBD
first one is
here

and all my columns are listed here

Texas Heart Institute at St. Luke’s Episcopal Hospital Leads World’s First Adult Stem Cell Study Using Patient’s Own Fat Tissue

more here ocal heart patient gives her account of taking part in stem cell research i could not find it in montgomerynews but its here and a patient account

New molecular switch for genes

Researchers have created a molecular switch that can reversibly turn any mammalian gene on or off and control its level of expression. The results, published this week in Cell, provide a new level of precision in studying genes involved in biological processes and diseases, the authors say.
more here

Copyright © 2007 Cell Press. All rights reserved.
Cell, Vol 130, 363-372, 27 July 2007
Resource
A Tunable Genetic Switch Based on RNAi and Repressor Proteins for Regulating Gene Expression in Mammalian Cells

Tara L. Deans,1 Charles R. Cantor,1 and James J. Collins1,
more here